← All patents

US20050112128A1

Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy …

University of Texas System

Abstract

The present invention provides for methods of treating and preventing cardiac hypertrophy and heart failure. MEF-2 and Class II HDACs have been shown to have a major role in cardiac hypertrophy and heart disease, and inhibition of class II HDAC's has been shown to have a beneficial, anti- …

University
University of Texas System
Assignee
Myogen, Inc. And Board Of Regents, The University Of Texas System
Inventor
Timothy McKinsey
Priority date
May 21, 2003
Filing date
May 19, 2004
Publication date
May 26, 2005
Language
en
Metadata fetched
August 28, 2026 23:58